-+ 0.00%
-+ 0.00%
-+ 0.00%

Opus Genetics shareholders approved authorized common stock increase to 250 million shares

PUBT·04/22/2026 10:17:19
Listen to the news
Opus Genetics shareholders approved authorized common stock increase to 250 million shares
  • Opus Genetics annual stockholders meeting was held on April 20, 2026.
  • Stockholders elected nine directors to one-year terms ending at 2027 annual meeting.
  • Ernst & Young was ratified as independent registered public accounting firm for fiscal year ending Dec. 31, 2026.
  • Amendment to restated certificate of incorporation to increase authorized common shares to 250 million from 125 million was adopted.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Opus Genetics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001140361-26-015990), on April 22, 2026, and is solely responsible for the information contained therein.